Ranger™ H74939419601590Recalls & reported problems
Boston Scientific Corporation · Paclitaxel-Coated PTA Balloon Catheter · Class 3
All models of Ranger (50)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08714729976196), received between Sep 1, 2021 and May 7, 2025 — classified as 5 malfunctions.
The most frequently reported specific device problem is “Material Rupture” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Material Rupture3
- Device Contamination with Chemical or Other Material1
- Entrapment of Device1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 7, 2025Material Rupture; Material Rupture
IT WAS REPORTED THAT BALLOON RUPTURE OCCURRED. THE 99% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND MODERATELY CALCIFIED SUPERFICIAL FEMORAL ARTERY. A 6.0 X 150MM, 90CM RANGER? BALLOON CATHETER WAS ADVANCED FOR DILATION. DURING THE PROCEDURE, THE BALLOON RUPTURED UPON FIRST INFLATION AT 6 ATMOSPHERES. THE DEVICE WAS REMOVED WITHOUT ANY PROBLEM, AND THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21979099 ↗MalfunctionApr 23, 2025Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT DEVICE CONTAMINATION OCCURRED. THE 75% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS SUPERFICIAL FEMORAL ARTERY. A 6.0 X 150MM, 90CM RANGER DRUG-COATED BALLOON WAS SELECTED FOR USE. HOWEVER, TWO THREAD-LIKE FOREIGN OBJECTS WERE NOTED ON THE DEVICE. THEY WERE PULLED BY FINGER, PEELED OFF FROM THE RANGER BALLOON, AND THE PROCEDURE WAS COMPLETED USING THIS DEVICE. THERE WERE NO PATIENT COMPLICATIONS AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21893680 ↗MalfunctionMar 6, 2024Entrapment of Device; Entrapment of Device
IT WAS REPORTED THAT CATHETER ENTRAPMENT OCCURRED. THE 99% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND SEVERELY CALCIFIED LEFT SUPERFICIAL FEMORAL ARTERY. A 6.0 X 150MM, 90CM RANGER PACLITAXEL-COATED PTA BALLOON CATHETER WAS ADVANCED FOR DILATION. DURING THE PROCEDURE, IT WAS NOTED THAT THE BALLOON BECAME STUCK WITH A 014 NON-BOSTON SCIENTIFIC GUIDEWIRE. BOTH DEVICES WERE REMOVED AS A SINGLE UNIT. THE PROCEDURE WAS COMPLETED USING THIS DEVICE. NO COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18848441 ↗MalfunctionOct 19, 2021Material Rupture; Material Rupture
IT WAS REPORTED THAT THE BALLOON RUPTURED. A 6.0 X 150MM, 90CM RANGER DRUG-COATED BALLOON WAS SELECTED FOR USE IN A PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) PROCEDURE IN THE LEFT SUPERFICIAL FEMORAL ARTERY (SFA). THE TARGET LESION WAS 99% STENOSED WITH MODERATE CALCIFICATION AND TORTUOSITY. THE BALLOON WAS INFLATED AT 8 ATM FOR 20 SECONDS DURING THE FIRST INFLATION AT WHICH POINT IT RUPTURED. THE BALLOON WAS REMOVED. A NEW DEVICE WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO PATIENT COMPLICATIONS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12662208 ↗MalfunctionSep 1, 2021Material Rupture; Material Rupture
IT WAS REPORTED THAT THE BALLOON RUPTURED. A 6.0 X 150MM, 90CM RANGER PACLITAXEL-COATED PTA BALLOON CATHETER WAS SELECTED FOR A PATIENT PROCEDURE IN THE RIGHT SUPERFICIAL FEMORAL ARTERY. THE PATIENT HAD PERIPHERAL ARTERY DISEASE. THE LESION WAS SEVERELY TORTUOUS, 99% STENOSED, AND MODERATELY CALCIFIED. DURING THE PROCEDURE, INSIDE OF THE PATIENT, THE BALLOON RUPTURED AT 10ATM DURING THE FIRST INFLATION. THE SHAPE OF THE RUPTURE WAS A PINHOLE. THE DEVICE WAS REMOVED WITHOUT ANY PROBLEMS. THE PATIENT WAS IN GOOD CONDITION AFTER THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12408917 ↗
Other Drug-Eluting Peripheral Transluminal Angioplasty Catheter devices
- LUTONIX® Drug Coated Balloon LX351305150Lutonix, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter117 reports
- LUTONIX® Drug Coated Balloon LX351306150Lutonix, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter75 reports
- Ranger™ H74939419502010Boston Scientific Corporation · Drug-Eluting Peripheral Transluminal Angioplasty Catheter71 reports
- Ranger™ H74939419602010Boston Scientific Corporation · Drug-Eluting Peripheral Transluminal Angioplasty Catheter71 reports
- Lutonix® Drug Coated Balloon LX351305100Lutonix, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter66 reports
- IN.PACT™ Admiral™ ADM06004013PMedtronic, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter1 recall12 reports
- IN.PACT™ Admiral™ ADM06015013PMedtronic, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter1 recall11 reports
- IN.PACT™ Admiral™ ADM04015013PMedtronic, Inc. · Drug-Eluting Peripheral Transluminal Angioplasty Catheter1 recall8 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page